World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
18105
World Ranking
2414
National Ranking
166

Overview

Thilo Jakob is affiliated with the University of Giessen in Germany. Their research primarily focuses on medicine, with a significant contribution of 82 publications. Within medicine, their work is concentrated in several subfields including immunology and allergy, dermatology, rheumatology, pharmacology, and genetics.

The main topics of Thilo Jakob's research include food allergy and anaphylaxis research, allergic rhinitis and sensitization, contact dermatitis and allergies, urticaria and related conditions, drug-induced adverse reactions, mast cells and histamine, as well as coagulation, bradykinin, polyphosphates, and angioedema.

The scientist has published numerous papers, some of the recent notable works being:

  • <scp>EAACI</scp> Molecular Allergology User's Guide 2.0, 2023, Pediatric Allergy and Immunology
  • Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020, 2020, International Archives of Allergy and Immunology
  • Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria, 2021, Allergy Asthma and Immunology Research
  • The global impact of the COVID-19 pandemic on the management and course of chronic urticaria, 2020, Allergy
  • Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA, 2021, Allergo Journal International

Frequent publication venues for their work include:

  • Allergo Journal
  • Allergy
  • Allergo Journal International
  • Allergologie select
  • Current Allergy and Asthma Reports

Thilo Jakob collaborates regularly with a set of co-authors who have contributed extensively alongside them. These frequent collaborators are:

  • Ludger Klimek
  • Wolfram Hötzenecker
  • Wolfgang Pfützner
  • Marcus Maurer
  • Martin Metz

Best Publications

  • EAACI Molecular Allergology User's Guide.

    P.M Matricardi;J Kleine-Tebbe;H.J Hoffmann;R Valenta

  • Genome-wide, large-scale production of mutant mice by ENU mutagenesis

    M. H. Hrabe de Angelis;H. Flaswinkel;H. Fuchs;B. Rathkolb

  • Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

    Allen P Kaplan;Dennis Ledford;Mark Ashby;Janice Canvin

  • Activation of Cutaneous Dendritic Cells by CpG-Containing Oligodeoxynucleotides: A Role for Dendritic Cells in the Augmentation of Th1 Responses by Immunostimulatory DNA

    Thilo Jakob;Patricia S. Walker;Arthur M. Krieg;Mark C. Udey

  • EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy

    G. J. Sturm;E.-M. Varga;G. Roberts;G. Roberts;H. Mosbech

  • Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.

    Gabriele Köllisch;Behnam Naderi Kalali;Verena Voelcker;Reinhard Wallich

  • Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

    Marcus Maurer;Sabine Altrichter;Thomas Bieber;Tilo Biedermann

  • Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin–derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity

    Esther von Stebut;Yasmine Belkaid;Thilo Jakob;David L. Sacks

  • Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization.

    Claudia Traidl-Hoffmann;Valentina Mariani;Hubertus Hochrein;Kathrin Karg

  • Mechanisms of chemical-induced innate immunity in allergic contact dermatitis.

    S. F. Martin;P. R. Esser;F. C. Weber;F. C. Weber;T. Jakob

  • Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence

    Marcus Maurer;Martin Metz;Randolf Brehler;Uwe Hillen

  • EAACI Molecular Allergology User's Guide 2.0

    Unknown

  • Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity

    Felix C. Weber;Philippp R. Esser;Philippp R. Esser;Tobias Müller;Jayanthi Ganesan;Jayanthi Ganesan

  • Association of NOD1 polymorphisms with atopic eczema and related phenotypes.

    Stephan Weidinger;Norman Klopp;Lars Rummler;Stefan Wagenpfeil

  • Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity

    Stefan F. Martin;Jan C. Dudda;Eva Bachtanian;Annalisa Lembo

  • Determinants of allergenicity

    Claudia Traidl-Hoffmann;Thilo Jakob;Heidrun Behrendt

  • Guideline for acute therapy and management of anaphylaxis

    Johannes Ring;Kirsten Beyer;Tilo Biedermann;Andreas J. Bircher

  • Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation.

    Philipp R. Esser;Ute Wölfle;Christoph Dürr;Friederike D. von Loewenich

  • Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

    Nicole Schoepke;Riccardo Asero;André Ellrich;Marta Ferrer

  • Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.

    Atfa Sassi;Sandra Lazaroski;Gang Wu;Stuart M. Haslam

  • Guideline for the diagnosis of drug hypersensitivity reactions

    Knut Brockow;Bernhard Przybilla;Werner Aberer;Andreas J. Bircher

  • Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung

    Francesca Alessandrini;Holger Schulz;Shinji Takenaka;Bernd Lentner

Frequent Co-Authors

Johannes Ring
Johannes Ring Technical University of Munich
Hans F. Merk
Hans F. Merk RWTH Aachen University
Heidrun Behrendt
Heidrun Behrendt Technical University of Munich
Ludger Klimek
Ludger Klimek Ghent University
Margitta Worm
Margitta Worm Charité - University Medicine Berlin
Tilo Biedermann
Tilo Biedermann Technical University of Munich
Torsten Zuberbier
Torsten Zuberbier Charité - University Medicine Berlin
Markus Ollert
Markus Ollert University of Southern Denmark
Knut Brockow
Knut Brockow Technical University of Munich
Thomas Werfel
Thomas Werfel Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology often leads students to consider complementary healthcare fields with strong growth potential. Nursing, for example, offers multiple accelerated paths suitable for those eager to enter the workforce quickly. Programs like the easiest accelerated nursing programs provide streamlined curriculums that make earning a Bachelor of Science in Nursing more accessible.

For those interested in starting clinical practice sooner, easy admission LPN programs present practical options to obtain a Licensed Practical Nurse credential with less competitive entry requirements. This can be a strategic step toward advanced nursing roles.

Nurse Practitioner programs represent a key career advancement, combining patient care with specialized knowledge. If you're seeking a manageable entry point, consider exploring what is the easiest NP program to fit your goals and lifestyle.

For professionals keen on mental health, the top PMHNP programs offer excellent clinical placement rates, blending online flexibility with crucial hands-on experience. These pathways align well with an immunology background for diversified healthcare career opportunities.

Best Scientists Citing Thilo Jakob

Trending Scientists